Recommendation ID
IPG572/1
Question

Current evidence on the safety and efficacy of irreversible electroporation for treating prostate cancer is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research. Studies should include randomised controlled trials comparing the procedure with current standards of care. They should report details of patient selection and short- and long-term outcomes, including patient-reported outcomes and the effect on any future prostate surgery.

Any explanatory notes
(if applicable)

None


Source guidance details

Comes from guidance
Irreversible electroporation for treating prostate cancer
Number
IPG572
Date issued
December 2016

Other details

Is this a recommendation for the use of a technology only in the context of research? Yes  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 31/12/2016